BIOSHIN
BioShin is a wholly owned subsidiary of Biohaven Pharmaceuticals, a public biotech company. BioShin is a clinical stage biopharmaceutical company focused on developing medicines. It has proven leadership from global industry and academic settings and a portfolio of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases, including rare disorders.
BIOSHIN
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2013-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.bioshin.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
60 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Font Awesome Mobile Non Scaleable Content Nginx
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Current Advisors List
Current Employees Featured
Founder
Investors List
OrbiMed
OrbiMed investment in Series A - BioShin
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series A - BioShin
Suvretta Capital Management
Suvretta Capital Management investment in Series A - BioShin
Surveyor Capital
Surveyor Capital investment in Series A - BioShin
Cormorant Asset Management
Cormorant Asset Management investment in Series A - BioShin
